A股異動 | 南寧糖業(000911.SZ)漲逾5% 擬向農投集團定增發行7623.89萬股 募資不超6億元
格隆匯6月22日丨南寧糖業(000911.SZ)漲逾5%,報9.72元,總市值32億元。南寧糖業昨日公佈,公司非公開發行的股票數量不超過7623.8881萬股(含本數),發行價格7.87元/股,不低於定價基準日前20個交易日公司股票交易均價的80%。發行對象為公司控股股東廣西農村投資集團有限公司。本次發行為面向特定對象的非公開發行,發行對象為農投集團。農投集團為公司控股股東,與公司構成關聯關係。農投集團擬以現金全額認購本次非公開發行的股票,認購金額不超過6億元(含本數)。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.